Literature DB >> 7200804

Arginase as an inhibitory principle in liver plasma membranes arresting the growth of various mammalian cells in vitro.

H Terayama, T Koji, M Kontani, T Okumoto.   

Abstract

Plasma membranes prepared from rat livers inhibited the in vitro growth of various mammalian cells including hepatoma cells in a concentration-dependent manner, showing almost complete arrest of cell growth at 0.1 mg protein/ml. Some of these cells tested, i.e., leukemia (L1210 and P388) and myeloma (P3-NS-1/1-Ag4-1) cells, were labile in the presence of plasma membranes (losing the viability), and CHO (Chinese hamster ovary) cells became round without detaching from the substratum. The culture medium preincubated with liver plasma membranes no longer supported the growth of hepatoma cells (AHI3 and AH66F). However, the 'conditioned' medium supplemented with L-arginine, supported the growth of the cells. Moreover, the addition of L-ornithine to the cultures containing plasma membranes markedly reduced the inhibitory effect of plasma membranes. The plasma membrane preparations were found to possess considerable arginase activity. There results seem to indicate the possible involvement of arginase in the inhibition of cell growth by liver plasma membranes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7200804     DOI: 10.1016/0167-4889(82)90011-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Partial purification of a liver-derived tumor cell growth inhibitor that differentially inhibits poorly-liver metastasizing cell lines: identification as an active subunit of arginase.

Authors:  P G Cavanaugh; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 2.  Growth inhibitors: molecular diversity and roles in cell proliferation.

Authors:  K Miyazaki; T Horio
Journal:  In Vitro Cell Dev Biol       Date:  1989-10

3.  Differential contribution of chemotaxins and opsonins to neutrophil-mediated killing of Schistosoma mansoni larvae.

Authors:  C H King; P J Spagnuolo; J J Ellner
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

Review 4.  Arginine dependence of tumor cells: targeting a chink in cancer's armor.

Authors:  M D Patil; J Bhaumik; S Babykutty; U C Banerjee; D Fukumura
Journal:  Oncogene       Date:  2016-04-25       Impact factor: 9.867

5.  Arginine deprivation and tumour cell death: arginase and its inhibition.

Authors:  Denys N Wheatley; Ruth Philip; Elaine Campbell
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

Review 6.  Arginine catabolism, liver extracts and cancer.

Authors:  Denys N Wheatley; Elaine Campbell
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

7.  Activity of a novel carotenoid analog, 4,4'-(3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaen -1,18- diyl) bis(1-ethylpyridinium) dibromide (Y-18598) on mouse leukemia P388.

Authors:  T Okumoto; N Morita; I Nakamura; M Konishi; M Yamaguchi
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

8.  Patterning of B16 melanoma metastasis and colonization generally relates to tumor cell growth-stimulating or growth-inhibiting effects of organs and tissues.

Authors:  E F Valle; A D Zalka; L Groszek; C W Stackpole
Journal:  Clin Exp Metastasis       Date:  1992-11       Impact factor: 5.150

9.  Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.

Authors:  Paulo C Rodriguez; Claudia P Hernandez; David Quiceno; Steven M Dubinett; Jovanny Zabaleta; Juan B Ochoa; Jill Gilbert; Augusto C Ochoa
Journal:  J Exp Med       Date:  2005-09-26       Impact factor: 14.307

10.  Structural characterization of the enzymes composing the arginine deiminase pathway in Mycoplasma penetrans.

Authors:  Pablo Gallego; Raquel Planell; Jordi Benach; Enrique Querol; Josep A Perez-Pons; David Reverter
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.